| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1177/1533317507302447 Apoptotic Gene Expression in Alzheimer's Disease Hippocampal TissueDivision of Geriatrics New York University School of Medicne, New York NY
Pulmonary Division New York University School of Medicine, New York, New York
Division of Geriatrics New York University School of Medicne, New York NY, david.marcus{at}med.nyu.edu
Alzheimer's Disease Research Center, Health Partners Research Foundation at Regions Hospital St. Paul, Minnesota
Division of Geriatrics New York University School of Medicne, New York NY
Alzheimer's Disease Research Center, Health Partners Research Foundation at Regions Hospital St. Paul, Minnesota
Division of Geriatrics New York University School of Medicne, New York NY
Alzheimer's disease (AD) is the major cause of dementia, accounting for 50% to 70% of the late-onset patients, with 17 to 20 million affected. It is characterized by neurofibrillary tangles, neuronal loss, and amyloid plaques in tissues of the cortex, hippocampus, and amygdala. Apoptosis or programmed cell death appears in the progression of AD. In this study, we investigated the gene expression of 14 apoptotic genes (E2F1, p21/WAF, ICE-LAP3, Fas Antigen, CPP-32, GADD153, ICE-ß, c-Fos, c-Jun, Bax-
Key Words: Alzheimer's disease apoptosis apoptotic gene expression reverse transcription-polymerase chain reaction human hippocampus
|
, Bcl-2, Bcl-(x)L, BAK, and p53) in 5 normal and 6 AD human hippocampal tissues, using reverse transcription-polymerase chain reaction. Our results show an upregulation of gene expression in AD patients for c-Fos and BAK. ICE-ß, c-Jun, Bax-